Learn more about who is eligible and what to expect at your initial appointment. Wegovy (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist, was first approved by the Food and Drug ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis ...